Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:dateCreated
2002-5-24
pubmed:abstractText
To determine the optimum dose of frovatriptan for the acute treatment of migraine.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
0017-8748
pubmed:author
pubmed:issnType
Print
pubmed:volume
42 Suppl 2
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
S74-83
pubmed:dateRevised
2010-11-18
pubmed:meshHeading
pubmed-meshheading:12028323-Acute Disease, pubmed-meshheading:12028323-Adolescent, pubmed-meshheading:12028323-Adult, pubmed-meshheading:12028323-Aged, pubmed-meshheading:12028323-Carbazoles, pubmed-meshheading:12028323-Dizziness, pubmed-meshheading:12028323-Dose-Response Relationship, Drug, pubmed-meshheading:12028323-Double-Blind Method, pubmed-meshheading:12028323-Fatigue, pubmed-meshheading:12028323-Female, pubmed-meshheading:12028323-Humans, pubmed-meshheading:12028323-Male, pubmed-meshheading:12028323-Middle Aged, pubmed-meshheading:12028323-Migraine Disorders, pubmed-meshheading:12028323-Nausea, pubmed-meshheading:12028323-Recurrence, pubmed-meshheading:12028323-Serotonin Receptor Agonists, pubmed-meshheading:12028323-Treatment Outcome, pubmed-meshheading:12028323-Tryptamines, pubmed-meshheading:12028323-United States
pubmed:year
2002
pubmed:articleTitle
Dose range-finding studies with frovatriptan in the acute treatment of migraine.
pubmed:affiliation
The New England Center for Headache, Stamford, Conn 06902-1251, USA.
pubmed:publicationType
Journal Article, Clinical Trial, Randomized Controlled Trial, Multicenter Study